The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
申请公布号
ZA200607134(B)
申请公布日期
2008.04.30
申请号
ZA20060007134
申请日期
2006.08.25
申请人
SCHERING CORPORATION
发明人
BOGEN, STEPHANE L.;RUAN, SUMEI;ARASAPPAN, ASHOK;NAIR, LATHA G.;BENNETT, FRANK;NJOROGE, F. GEORGE;PAN, WEIDONG;CHEN, KEVIN X.;VENKATRAMAN, SRIKANTH;SANNIGRAHI, MOUSUMI;SAKSENA, ANIL K.;GIRIJAVALLABHAN, VIYYOOR M.
